Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CA 4. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN118993873A enables high-purity 1,4-NDA synthesis with reduced waste and scalable operations for global supply chains ensuring reliability.
Patent CN117843716A details a novel refining method for Carfilzomib removing oxidation and isomer impurities ensuring high purity and supply chain reliability for global pharmaceutical manufacturers.
Efficient enantioselective synthesis method for tea geometrid pheromone intermediates. Reduces cost and improves supply chain reliability for agrochemical manufacturers.
Patent CN102924380A details a high-yield Imidocarb process using P-Mo-V catalysts. Achieve >99% purity and reduced waste for reliable veterinary intermediate supply chains.
Novel enzymatic resolution and atmospheric coupling process for high-purity pharmaceutical intermediates ensuring cost reduction and supply reliability.
Novel synthetic route for key pharmaceutical intermediate reduces cost and complexity. Reliable supplier offering scalable production and high purity specifications for global supply chains.
Patent CN108299428A details novel dual-target HIV inhibitors. Discover cost-effective manufacturing and supply chain solutions for high-purity pharmaceutical intermediates.
Patent CN103159672A details a novel tropicamide preparation using phenyl ethyl malonate, offering cost reduction in pharmaceutical manufacturing and improved supply chain reliability.
Novel Pd-catalyzed domino reaction for high-purity carbazole derivatives. Cost-effective route for pharmaceutical intermediates and optoelectronic materials.
Patent CN110981883B reveals a superior 2-step synthesis for Ticagrelor intermediates. Discover cost-effective manufacturing and reliable supply chain solutions for API production.
Patent CN111548372A reveals a novel iridium-carbene complex enabling room-temperature photocatalysis, offering significant cost reduction in fine chemical manufacturing and reliable supply.
Novel 3-step synthesis for high-purity Aztreonam Dimer. Reduces reaction time from 80h to 22h. Ideal for QC reference standards and reliable pharma supplier needs.
Patent CN109942514B details a cost-effective L-phenylalanine route for Atazanavir intermediates, offering high purity and scalable manufacturing solutions.
Patent CN120554343A reveals new iron and palladium catalytic route. Improves yield and safety for empagliflozin manufacturing supply chain.
Novel patent CN114671782A details a scalable synthesis of chiral halohydrin amines from L-phenylalanine, offering high purity and cost-effective manufacturing for antiviral intermediates.
Patent CN1314880A details a novel enantioselective hydrocyanation method for producing high-purity optically active alpha-aminonitriles, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Advanced synthetic route for Quetiapine Hemifumarate using o-bromonitrobenzene. Offers mild conditions, high purity, and cost reduction in API manufacturing.
Novel patent CN101591346B details high-yield synthesis route offering substantial cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing.
Patent CN102070483A reveals acetone-based lidocaine synthesis offering higher purity and environmental benefits for reliable pharmaceutical intermediate supply chains.
Patent CN102101838A reveals a novel chiral resolution route for Mitiglinide Calcium, offering significant cost reduction and high purity for global API manufacturing supply chains.